{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:20:03Z","timestamp":1784236803067,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2019.0467"],"award-info":[{"award-number":["2019.0467"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2013\/03537"],"award-info":[{"award-number":["2013\/03537"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\/02559"],"award-info":[{"award-number":["2018\/02559"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.heliyon.2021.e07808","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T11:17:58Z","timestamp":1628939878000},"page":"e07808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3657-3711","authenticated-orcid":false,"given":"Jo B.","family":"Henningsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-5322","authenticated-orcid":false,"given":"Rana","family":"Soylu-Kucharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e07808_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2021.e07808_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e07808_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heliyon.2021.e07808_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","article-title":"Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization","volume":"119","author":"Ferrante","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2021.e07808_bib6","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2021.e07808_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.heliyon.2021.e07808_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.heliyon.2021.e07808_bib9","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1603871113","article-title":"Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease","volume":"113","author":"Molero","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2021.e07808_bib10","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heliyon.2021.e07808_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JHD-129005","article-title":"Age-dependent resistance to excitotoxicity in Htt CAG140 mice and the effect of strain background","volume":"1","author":"Strong","year":"2012","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.heliyon.2021.e07808_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JHD-190372","article-title":"The role of hypothalamic pathology for non-motor features of Huntington's disease","volume":"8","author":"Cheong","year":"2019","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.heliyon.2021.e07808_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2021.e07808_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","article-title":"Hypocretin and melanin-concentrating hormone in patients with Huntington disease","volume":"18","author":"Aziz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/nan.12236","article-title":"Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study","volume":"41","author":"Gabery","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/nan.12514","article-title":"SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease","volume":"45","author":"Baldo","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2021.e07808_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2021.e07808_bib20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","article-title":"Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction","volume":"19","author":"Yamanaka","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2021.e07808_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib22","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease","volume":"22","author":"Hult Lundh","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2021.e07808_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1212\/WNL.43.8.1593","article-title":"AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease","volume":"43","author":"Kremer","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2021.e07808_bib24","first-page":"2923","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease","volume":"25","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2021.e07808_bib25","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heliyon.2021.e07808_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuroscience.2010.06.081","article-title":"Quinolinate induces selective loss of melanin-concentrating hormone neurons, rather than orexin neurons, in the hypothalamus of mice and young rats","volume":"170","author":"Obukuro","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2021.e07808_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2003.09.003","article-title":"Excitotoxic degeneration of hypothalamic orexin neurons in slice culture","volume":"15","author":"Katsuki","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.heliyon.2021.e07808_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.heliyon.2021.e07808_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington's disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.heliyon.2021.e07808_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/exnr.2002.7885","article-title":"Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease","volume":"175","author":"Petersen","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.brainresbull.2006.01.003","article-title":"Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat","volume":"69","author":"Winkler","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.heliyon.2021.e07808_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.bjp.0704613","article-title":"Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists","volume":"135","author":"Behan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2021.e07808_bib33","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00429-017-1466-3","article-title":"The excitatory\/inhibitory input to orexin\/hypocretin neuron soma undergoes day\/night reorganization","volume":"222","author":"Laperchia","year":"2017","journal-title":"Brain Struct. Funct."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021019113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021019113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T04:33:02Z","timestamp":1767760382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021019113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2405844021019113"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07808","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.08.439100","asserted-by":"object"}]},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e07808"}}